Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Window of Opportunity" Phase I Trial of Focal Radiotherapy and Bintrafusp Alfa In Patients With Advanced Intrahepatic Cholangiocarcinoma

NCT04708067 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04708067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Window of Opportunity" Phase I Trial of Focal Radiotherapy and Bintrafusp Alfa In Patients With Advanced Intrahepatic Cholangiocarcinoma
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 31, 2021
Completion date
February 2, 2027
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced intrahepatic cholangiocarcinoma, metastatic intrahepatic cholangiocarcinoma, stage iii intrahepatic cholangiocarcinoma ajcc v8, stage iiia intrahepatic cholangiocarcinoma ajcc v8, stage iiib intrahepatic cholangiocarcinoma ajcc v8, stage iv intrahepatic cholangiocarcinoma ajcc v8